Atlas Trials

Efficacy of Imatinib in Patients With Intermediate-risk Gastrointestinal Stromal Tumor With a High-risk Genomic Grade Index

Clinical trial NCT02576080 · UNKNOWN

Trial details

NCT number
NCT02576080
Sponsor
Assistance Publique Hopitaux De Marseille
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Gastrointestinal Stromal Tumor
Start date
2015-10-01
Primary completion
2019-10-01
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.